Target intelligence / Profile preview

Eleven-nineteen leukemia protein YEATS domain (ENL YEATS domain)

Target
ENL YEATS domain
Molecular classification
Chromatin reader, Epigenetic regulator, Histone modification reader, Transcriptional co-regulator
01

Overview

The Eleven-nineteen leukemia protein YEATS domain is a specialized protein module found in key transcriptional co-regulators (ENL, AF9, GAS41, YEATS2). It possesses an immunoglobulin-like β-sandwich fold with a ligand-binding pocket that selectively recognizes acylated lysines (e.g., acetylation, crotonylation) on histone tails, thereby acting as an epigenetic reader[1][5]. This recognition is crucial for recruiting chromatin-modifying complexes involved in gene activation or repression. YEATS domain-containing proteins regulate transcriptional elongation, chromatin remodeling, and are implicated in cancer pathogenesis, particularly leukemia, due to their fusion with MLL in oncogenic translocations[2][4][5]. Drug discovery efforts have begun to target this domain, exploiting its role in transcriptional control and tumorigenesis[4][5].

Other names
ENL YEATS domainMLLT1YEATS1YEATS domain-containing proteinYD proteins
02

Mechanism of action

Inhibition of YEATS domain prevents recognition of acetylated and acylated lysine on histones, disrupting recruitment of transcriptional complexes and chromatin remodeling machinery, and potentially blocking oncogenic transcriptional programs

03

Biological functions

Epigenetic regulationHistone acylation binding (acyllysine recognition)Chromatin remodelingTranscriptional elongationRecruitment of chromatin modifying complexes
04

Disease associations

Cancer (especially leukemia and non-small cell lung cancer)Neurological diseases (potentially implicated)Neurodevelopmental disorders
05

Safety considerations

Potential for broad effects on gene expression due to inhibition of chromatin reading abilityUnknown long-term effects due to the essential roles in cell proliferation and differentiation
06

Interacting drugs

Small molecule inhibitors of YEATS domain (e.g., pyrazolopyridine series labeled as probes for YEATS4/YEATS2)

1 more in the full profile.

07

Biomarkers

Mutations or overexpression of YEATS domain-containing proteins (ENL, AF9, GAS41, YEATS2)Specific histone acetylation marks (such as H3K9ac, H3K18ac, H3K27ac) recognized by YEATS domain

Beyond the preview

Go deeper on Eleven-nineteen leukemia protein YEATS domain (ENL YEATS domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eleven-nineteen leukemia protein YEATS domain (ENL YEATS domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call